Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Imatanib a targeted oral medication classified as a tyrosine kinase inhibitor. It is primarily used to treat certain types of leukemia (such as chronic myeloid leukemia) and specific digestive or skin tumors by blocking abnormal proteins that drive cancer cell growth.
Imatanib a targeted oral medication classified as a tyrosine kinase inhibitor. It is primarily used to treat certain types of leukemia (such as chronic myeloid leukemia) and specific digestive or skin tumors by blocking abnormal proteins that drive cancer cell growth.